Price $279.52 |
Market Cap
111.12B
|
Sector Health Care |
Div. Growth
10.00%
|
|
P/E
31.1
|
P/B
3.97
|
P/S
4.42
|
Dividend %
0.30%
|
|
P/CF
147.6
|
P/FCF
31.7
|
Op. Cash Flow
4.54M
|
FCF
8.6
|
|
Op. Margin
15.20%
|
Net Margin
11.80%
|
ROE
10.80%
|
ROI
7.70%
|
|
ROA
5.30%
|
EPS Growth
28.90%
|
Current Ratio
1.7
|
Debt/Equity
64.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MTBC Inc (MTBC) | $4.62 | - | - | 58.6M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.46 | - | - | 6.1M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.96 | - | - | 43.3M | Strong Buy |
| IRIDEX Corporation (IRIX) | $2.72 | - | - | 47.2M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.96 | - | - | 240.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
